Comparative Effectiveness of Anti-IL5/5R Versus Anti-IgE in Patients Eligible for Both (FIRE)
| dc.contributor.author | Ali, N. | |
| dc.contributor.author | Lyu, J. | |
| dc.contributor.author | Newell, A. | |
| dc.contributor.author | Sadatsafavi, M. | |
| dc.contributor.author | Tran, T. N. | |
| dc.contributor.author | Price, D.B. | |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2024-08-22T09:48:01Z | |
| dc.date.available | 2024-08-22T09:48:01Z | |
| dc.date.issued | 2021-09-05 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 2 | |
| dc.format.extent | 102159 | |
| dc.identifier | 292784131 | |
| dc.identifier | a9f5d717-46cf-4c06-a8c8-faa94287339a | |
| dc.identifier.citation | Ali, N, Lyu, J, Newell, A, Sadatsafavi, M, Tran, T N & Price, D B 2021, 'Comparative Effectiveness of Anti-IL5/5R Versus Anti-IgE in Patients Eligible for Both (FIRE)', European Respiratory Journal, vol. 58, no. 65, PA1113. https://doi.org/10.1183/13993003.congress-2021.PA1113 | en |
| dc.identifier.doi | 10.1183/13993003.congress-2021.PA1113 | |
| dc.identifier.iss | 65 | en |
| dc.identifier.issn | 0903-1936 | |
| dc.identifier.uri | https://hdl.handle.net/2164/24090 | |
| dc.identifier.vol | 58 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | European Respiratory Journal | en |
| dc.subject | Asthma | en |
| dc.subject | Management | en |
| dc.subject | Severe asthma | en |
| dc.subject | Treatments | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | Comparative Effectiveness of Anti-IL5/5R Versus Anti-IgE in Patients Eligible for Both (FIRE) | en |
| dc.type | Journal item | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Ali_etal_ERS_Comparative_Effectiveness_Of_AAM.pdf
- Size:
- 99.76 KB
- Format:
- Adobe Portable Document Format
